Regenerative Biologics • Peptide Therapy • Practice Compliance
Regenerative medicine and peptide therapy are moving rapidly into medical aesthetics, wellness, and longevity practices—but adding these treatments involves much more than choosing the latest product.
Where was it sourced? How was it manufactured? What documentation supports it? And how should a medical practice evaluate the clinical and regulatory considerations before offering it to patients?
In this episode of Meet the Experts, JR Burgess sits down with Dr. Roy “Buzz” Korth, D.C., ABAAHP, FSCT, FAAMF, founder of Comprehensive Biosciences, Push Patch, Pinnacle Biolab, and Buckeye Anti-Aging, for a conversation about regenerative biologics, birth tissue products, exosomes, peptides, transdermal delivery—and the importance of building these services on a responsible foundation.
Regenerative Medicine Is Growing. So Is the Need for Due Diligence.
Patient interest in regenerative medicine, peptides, exosomes, and longevity therapies continues to create new opportunities for medical practices.
But opportunity alone is not a clinical strategy.
Dr. Korth emphasizes understanding exactly what a practice is purchasing and using—from the origin and handling of biologic products to Certificates of Analysis, manufacturing practices, documentation, and vendor transparency.
The conversation offers providers a practical framework for asking better questions before bringing a new product or protocol into the practice.
In This Episode
- Differences among exosomes, Wharton’s Jelly, and Muse cell-derived products
- How to evaluate regenerative manufacturers and suppliers
- Why traceability, sourcing, documentation, and Certificates of Analysis matter
- How peptides may be incorporated into regenerative and aesthetic protocols
- Roles discussed for GHK-Cu, BPC-157, TB-500, KPV, NAD+ and glutathione
- Microneedle and iontophoresis-based delivery
- Marketing and patient-documentation considerations
- Structuring regenerative offerings at different investment levels
The Companies & Technologies Discussed
Comprehensive Biosciences
Dr. Korth’s regenerative tissue organization focused on biologic products and regenerative applications. The episode explores its approach to tissue sourcing, processing, documentation, quality control, and vertical integration.
Push Patch Glow
A transdermal aesthetic delivery approach combining microneedle technology with iontophoresis. The supplied materials state Glow incorporates GHK-Cu with BPC-157, TB-500, and NAD+.
Pinnacle Biolab
Focused on provider-sourced peptide products. Dr. Korth discusses GHK-Cu, BPC-157, TB-500, KPV, NAD+, and glutathione while emphasizing sourcing, documentation, and appropriate clinical supervision.
A Framework for Building Regenerative Services
GOOD
Peptide therapy as a more accessible standalone or ongoing option.
BETTER
BEST
Special Offer for Meet the Experts Viewers
Save 10% on Your First Order
Dr. Roy “Buzz” Korth is extending Meet the Experts viewers an introductory 10% discount on their first eligible order across Comprehensive Biosciences, Push Patch Glow, and Pinnacle Biolab.
Mention this Meet the Experts episode when contacting Dr. Korth.
Phone: 614-562-9110 | Email: Drbuzzk@gmail.com
Meet the Experts
Dr. Roy “Buzz” Korth
Founder — Comprehensive Biosciences | Push Patch | Pinnacle Biolab | Buckeye Anti-Aging
Dr. Roy “Buzz” Korth, D.C., ABAAHP, FSCT, FAAMF, has spent approximately two decades working in regenerative and functional medicine. His work spans regenerative biologics, tissue products, peptide therapy, anti-aging medicine, and emerging delivery technologies.
Through his companies, Dr. Korth works with medical professionals seeking to incorporate regenerative approaches into patient care while emphasizing sourcing, documentation, product understanding, and responsible implementation.
JR Burgess
Executive Business Advisor | MD Business Advisors
JR Burgess is an Executive Business Advisor and healthcare growth strategist who helps doctors build thriving cash-based clinics with stronger systems, better teams, and measurable patient outcomes.
Having served in fractional leadership roles spanning CEO, COO, CFO, CRO, and CMO responsibilities, JR brings hands-on experience across the major functions of clinic growth. He helps medical professionals move beyond clinical education into leadership, implementation, scalability, and sustainable business growth.
